Afinitor and Gaviscon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Afinitor (everolimus) and Gaviscon (aluminum hydroxide; magnesium trisilicate). Common drug interactions include alanine aminotransferase increased among females and confusional state among males.

The phase IV clinical study analyzes what interactions people have when they take Afinitor and Gaviscon. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.

What is Afinitor?

Afinitor has active ingredients of everolimus. It is often used in breast cancer metastatic. eHealthMe is studying from 41,680 Afinitor users. Check the latest studies of Afinitor.

What is Gaviscon?

Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,355 Gaviscon users. Check the latest studies of Gaviscon.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

23 people who take Afinitor and Gaviscon together, and have interactions are studied.

Afinitor and Gaviscon drug interactions.

What are the common drug interactions of Afinitor and Gaviscon, by gender? *:

female:

Alanine aminotransferase increased
Abdominal pain upper
Alopecia (absence of hair from areas of the body)
Anxiety
Back pain
Dry skin
Eyelid oedema (eyelids are swollen and contain excessive fluid)
Femoral neck fracture (neck of femur bone fracture)
Flatulence (flatus expelled through the anus)
Gamma-glutamyltransferase increased

male:

Confusional state
General physical health deterioration (weak health status)
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Respiratory disorder (respiratory disease)
Urinary retention (the inability to completely or partially empty the bladder)
Epistaxis (bleed from the nose)
Pneumonia
Hypoxia (low oxygen in tissues)
Lung disorder (lung disease)
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)

What are the common drug interactions of Afinitor and Gaviscon, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Confusional state
General physical health deterioration (weak health status)
Hypoxia (low oxygen in tissues)
Lung disorder (lung disease)
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
Nervous system disorder (a general class of medical conditions affecting the nervous system)
Pyrexia (fever)
Septic shock (shock due to blood infection)
Spinal cord compression
Respiratory disorder (respiratory disease)

60+:

Alanine aminotransferase increased
Abdominal pain upper
Hypercholesterolaemia (high levels of cholesterol in the blood)
Intestinal obstruction
Rash
Aphthous ulcer (mouth ulcer)
Hypokalaemia (low potassium)
Insomnia (sleeplessness)
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

High Blood Pressure: 11 people, 47.83%
Renal Cell Carcinoma (a kidney cancer): 9 people, 39.13%
Stress And Anxiety: 5 people, 21.74%
Pain: 5 people, 21.74%
Hypokalemia (low potassium): 5 people, 21.74%
Diarrhea: 5 people, 21.74%
Constipation: 5 people, 21.74%
Carcinoid Tumor: 5 people, 21.74%
Carcinoid Syndrome (syndrome includes flushing and diarrhoea, and, less frequently, heart failure and bronchoconstriction): 5 people, 21.74%
Hypertriglyceridaemia (excess of triglycerides in the blood): 4 people, 17.39%

* Approximation only. Some reports may have incomplete information.

Do you take Afinitor and Gaviscon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously